Monitoring neoadjuvant chemotherapy in breast cancer using quantitative diffuse optical spectroscopy: a case study.
about
Imaging in breast cancer: diffuse optics in breast cancer: detecting tumors in pre-menopausal women and monitoring neoadjuvant chemotherapyImaging Breast Density: Established and Emerging Modalities.Optical imaging for breast cancer prescreening.Diffuse Optical Monitoring of the Neoadjuvant Breast Cancer Therapy.Photoacoustic signal characterization of cancer treatment response: Correlation with changes in tumor oxygenation.Optimal wavelengths for optoacoustic measurements of blood oxygen saturation in biological tissues.Multiparametric monitoring of chemotherapy treatment response in locally advanced breast cancer using quantitative ultrasound and diffuse optical spectroscopyWavelength-modulated differential photoacoustic radar imager (WM-DPARI): accurate monitoring of absolute hemoglobin oxygen saturation.Diffuse Optics for Tissue Monitoring and Tomography.Towards non-invasive characterization of breast cancer and cancer metabolism with diffuse optics.In vivo water state measurements in breast cancer using broadband diffuse optical spectroscopy.Spatial and spectral information in optical mammography.NIR spectroscopic detection of breast cancer.Diffuse optical tomography of breast cancer during neoadjuvant chemotherapy: a case study with comparison to MRI.Spectral and temporal near-infrared imaging of ex vivo cancerous and normal human breast tissues.Coregistration of dynamic contrast enhanced MRI and broadband diffuse optical spectroscopy for characterizing breast cancer.Combined diffuse optical tomography (DOT) and MRI system for cancer imaging in small animals.Predicting response to breast cancer neoadjuvant chemotherapy using diffuse optical spectroscopyAssessing the future of diffuse optical imaging technologies for breast cancer managementDiffuse optical spectroscopy measurements of healing in breast tissue after core biopsy: case studyEffect of contact force on breast tissue optical property measurements using a broadband diffuse optical spectroscopy handheld probe.Characterization of metabolic differences between benign and malignant tumors: high-spectral-resolution diffuse optical spectroscopy.Imaging breast cancer chemotherapy response with light. Commentary on Soliman et al., p. 2605.Feasibility of near-infrared diffuse optical spectroscopy on patients undergoing imageguided core-needle biopsyOptically measured microvascular blood flow contrast of malignant breast tumors.In vivo near-infrared spectroscopy and magnetic resonance imaging monitoring of tumor response to combretastatin A-4-phosphate correlated with therapeutic outcome.In vivo hyperspectral imaging of microvessel response to trastuzumab treatment in breast cancer xenografts.Optical imaging of breast cancer oxyhemoglobin flare correlates with neoadjuvant chemotherapy response one day after starting treatment.Near-infrared tomography of breast cancer hemoglobin, water, lipid, and scattering using combined frequency domain and cw measurementHaemoglobin oxygen saturation as a biomarker: the problem and a solutionDiffuse optical spectroscopic imaging correlates with final pathological response in breast cancer neoadjuvant chemotherapy.Frequent optical imaging during breast cancer neoadjuvant chemotherapy reveals dynamic tumor physiology in an individual patient.Multi-projection fluorescence optical tomography using a handheld-probe-based optical imager: phantom studies.Molecular imaging of water binding state and diffusion in breast cancer using diffuse optical spectroscopy and diffusion weighted MRIOptical breast cancer margin assessment: an observational study of the effects of tissue heterogeneity on optical contrast.Rapid and accurate determination of tissue optical properties using least-squares support vector machines.Optical tomography with ultrasound localization: initial clinical results and technical challenges.Optical mammography: Diffuse optical imaging of breast cancer.Gen-2 hand-held optical imager towards cancer imaging: reflectance and transillumination phantom studies.Predicting Responses to Neoadjuvant Chemotherapy in Breast Cancer: ACRIN 6691 Trial of Diffuse Optical Spectroscopic Imaging
P2860
Q25257651-B5DE30A9-E0FF-43C5-B01C-9CF611ABEFCDQ26773994-5747274C-DB08-4CAE-9847-328C8BA0E700Q26801115-1651B17F-5F17-4C44-BEE3-2D43204DF26FQ28710339-D046CEF9-C770-4A4C-89CF-47AECAB45858Q30359234-B72F3933-06A0-4218-9AA3-4BC9A1B9C6DFQ30369573-D41E79A8-238D-4498-8564-69F9F8A173DBQ30375438-09649031-82B1-4848-B433-797AC8F9D4CEQ30378417-AC3B4FB1-BC1D-450F-BC1B-EA51148EBA45Q30408498-63D28434-D66A-4CE5-8FB1-45E430BFD6CBQ30435832-A62041DD-BB16-47A9-9B32-CB17D7FB2E7EQ30853219-A278DEAD-EC84-450D-90AB-0E81DB491542Q31005907-C7313921-9DFE-45F9-A2A1-F2F582E27F78Q31005913-724504CC-ACA0-4F77-A1B8-5FE69E58EC2EQ33215142-D784F925-D1FC-443A-A35A-072EA4A309BEQ33223640-17941D67-AA1C-478B-AAC6-3972D791F549Q33223642-74CA5A98-7C83-4758-882E-429858B31966Q33251691-84A6C421-64E4-4679-A772-AD878C04DE25Q33278673-0CAEDE60-34D7-44EC-9E02-2996D69E90F7Q33354277-5408F012-1DAD-4007-98FF-B092327C97DEQ33414280-47573136-5284-46BE-B503-652D3FCCCC81Q33485199-47ACCDC7-832A-4A8A-92D0-B800ABFB50A9Q33520641-1373AB46-71DC-4AD4-AD1C-241F3375CE37Q33560611-D5B775F4-2878-4591-91BB-72E98FDC4393Q33572583-E3C3FA26-B20E-4CAD-ACF0-8839AB2A9583Q33812407-463E7725-874D-40D0-BAD0-036F7BCAF6CAQ33827707-92990012-33AA-4966-A5D6-602263B3A446Q33915825-08AB0CEF-93DA-4F37-A31A-ED351428DBACQ33996547-D2EBC136-3697-42DC-BA7A-38BF6D57909FQ34030357-684E17DC-3611-47AE-8854-E3974A4495CFQ34050332-563E405D-2704-46AB-9C9D-49B2E62C36E9Q34050338-93A9DA8F-EB9E-4FD1-A971-557D6CF8E2DAQ34074868-906D9CF1-AFC1-43CD-8C1C-BCF829FCD762Q34287317-459A21A3-2430-40F8-B2CE-D889F586D619Q34380422-00BE3464-D7C8-42C8-A45F-819DC4C97879Q34613500-91FCFDD1-E36D-4932-8AF9-EBA56123BD73Q34617774-FB1737ED-FEA7-4514-9442-956D87C7B84EQ34943898-B047C823-39BD-4AE7-BF34-4F0C9C7A58A0Q34983828-C7D90D93-2091-4FA2-99DE-DAFA4F55570DQ35831431-18D8C6D8-5C25-4ACF-BC3B-348EA9DBE7E3Q36104503-D82220A3-1D79-4446-977B-ACE524332E19
P2860
Monitoring neoadjuvant chemotherapy in breast cancer using quantitative diffuse optical spectroscopy: a case study.
description
2004 nî lūn-bûn
@nan
2004 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Monitoring neoadjuvant chemoth ...... al spectroscopy: a case study.
@ast
Monitoring neoadjuvant chemoth ...... al spectroscopy: a case study.
@en
type
label
Monitoring neoadjuvant chemoth ...... al spectroscopy: a case study.
@ast
Monitoring neoadjuvant chemoth ...... al spectroscopy: a case study.
@en
prefLabel
Monitoring neoadjuvant chemoth ...... al spectroscopy: a case study.
@ast
Monitoring neoadjuvant chemoth ...... al spectroscopy: a case study.
@en
P2093
P356
P1476
Monitoring neoadjuvant chemoth ...... al spectroscopy: a case study.
@en
P2093
Albert E Cerussi
David Hsiang
Dorota B Jakubowski
Frédéric Bevilacqua
John Butler
Natasha Shah
P304
P356
10.1117/1.1629681
P577
2004-01-01T00:00:00Z